Enzeevu – Talk Bio

Actionable Insights Powered by AI

Regeneron and Sandoz Settle Eylea Biosimilar Patent Dispute

Regeneron; Sandoz; Eylea; Enzeevu; biosimilar; aflibercept; patent settlement; FDA approval; U.S. launch; ophthalmology